Podcast: Syngene CEO On Sub-Dynamics As US Biotech Funding Finds New Normal, ADC Capabilities

 
• By Anju Ghangurde
  
Jonathan Hunt, MD & CEO, Syngene International • Source: Syngene
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip